{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:06:24Z","timestamp":1747181184382,"version":"3.40.5"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"46","license":[{"start":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T00:00:00Z","timestamp":1700179200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,11,17]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Autosomal recessive Alport syndrome (ARAS) is an hereditary heterogeneous disease that poses a serious risk to pregnant women.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>We reported 2 cases of pregnancy with progressive proteinuria. The case 1 was a 21-year-old woman with 24-h proteinuria increased from 2.03 to 11.72\u2009g at 13 to 35 weeks of gestation, and the case 2 was a 28-year-old woman with 24-h proteinuria increased from 2.10 to 9.32\u2009g at 8 to 36 weeks of gestation. In advanced stage of pregnancy, the fetal development was smaller than the gestational age.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>Sanger sequencing showed that novel compound heterozygous mutations [c.1315 G&gt;T (p.G439C) and c.4847 G&gt;A (p.C1616Y)] of the collagen type IV alpha 3 chain (<jats:italic toggle=\"yes\">COL4A3<\/jats:italic>) gene were found in the 2 cases. Renal puncture pathology confirmed the diagnosis of ARAS.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>The 2 cases were treated with albumin, compounded amino acids, calcium, vitamin D, and low molecular weight heparin in addition to conventional treatment during pregnancy. Pregnancy was terminated by cesarean section at 36 to 37 weeks of gestation. After delivery, the patients were treated with Losartan for anti-proteinuric therapy for 1 year.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The neonatal weights and Apgar scores were normal. The patients recovered well and 24-h proteinuria decreased to pre-pregnancy level.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>When pregnant women present with a persistent increasing proteinuria, ARAS needs to be considered. Sanger sequencing is useful to assist in the diagnosis of ARAS. Multidisciplinary treatments from nephrologists and gynecologists are needed to ensure the safety of pregnancy and the fetus.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000036057","type":"journal-article","created":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T09:19:32Z","timestamp":1701163172000},"page":"e36057","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Pregnancy in women with autosomal recessive Alport syndrome caused by novel compound heterozygous mutations of COL4A3 gene: Two cases reports"],"prefix":"10.1097","volume":"102","author":[{"given":"Xiaoli","family":"Gao","sequence":"first","affiliation":[{"name":"Department of Gynecology and Obstetrics, Tianjin Medical University General Hospital, Tianjin, China"},{"name":"Tianjin Key Laboratory of Female Reproductive Health and Eugenics, Tianjin Medical University General Hospital, Tianjin, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meilu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Tianjin Medical University General Hospital, Tianjin, China"},{"name":"Tianjin Key Laboratory of Female Reproductive Health and Eugenics, Tianjin Medical University General Hospital, Tianjin, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Tianjin Medical University General Hospital, Tianjin, China"},{"name":"Tianjin Key Laboratory of Female Reproductive Health and Eugenics, Tianjin Medical University General Hospital, Tianjin, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zengyan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Tianjin Medical University General Hospital, Tianjin, China"},{"name":"Tianjin Key Laboratory of Female Reproductive Health and Eugenics, Tianjin Medical University General Hospital, Tianjin, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7191-1563","authenticated-orcid":false,"given":"Cha","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Tianjin Medical University General Hospital, Tianjin, China"},{"name":"Tianjin Key Laboratory of Female Reproductive Health and Eugenics, Tianjin Medical University General Hospital, Tianjin, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.xkme.2020.05.014","article-title":"Alport syndrome classification and management.","volume":"2","author":"Warady","year":"2020","journal-title":"Kidney Med"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00467-020-04819-6","article-title":"Clinical practice recommendations for the diagnosis and management of Alport syndrome in children, adolescents, and young adults-an update for 2020.","volume":"36","author":"Kashtan","year":"2021","journal-title":"Pediatr Nephrol"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"5602","DOI":"10.2174\/0929867328666210108113500","article-title":"Alport syndrome: a comprehensive review on genetics, pathophysiology, histology, clinical and therapeutic perspectives.","volume":"28","author":"Pedrosa","year":"2021","journal-title":"Curr Med Chem"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s10157-018-1629-4","article-title":"A review of clinical characteristics and genetic backgrounds in Alport syndrome.","volume":"23","author":"Nozu","year":"2019","journal-title":"Clin Exp Nephrol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1053\/j.ajkd.2020.03.026","article-title":"Alport syndrome: achieving early diagnosis and treatment.","volume":"77","author":"Kashtan","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s11255-012-0154-8","article-title":"Pregnancy in women with Alport syndrome.","volume":"45","author":"Crovetto","year":"2013","journal-title":"Int Urol Nephrol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s00467-018-3985-4","article-title":"Expert consensus guidelines for the genetic diagnosis of Alport syndrome.","volume":"34","author":"Savige","year":"2019","journal-title":"Pediatr Nephrol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1159\/000502147","article-title":"Autosomal recessive Alport syndrome unveiled by pregnancy.","volume":"143","author":"Drury","year":"2019","journal-title":"Nephron"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1681\/ASN.2012100985","article-title":"COL4A3\/COL4A4 mutations and features in individuals with autosomal recessive Alport syndrome.","volume":"24","author":"Storey","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3390\/jcm8020178","article-title":"Features of autosomal recessive Alport syndrome: a systematic review.","volume":"8","author":"Lee","year":"2019","journal-title":"J Clin Med"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/cge.12247","article-title":"A founder mutation in COL4A3 causes autosomal recessive Alport syndrome in the Ashkenazi Jewish population.","volume":"86","author":"Webb","year":"2014","journal-title":"Clin Genet"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1089\/gtmb.2012.0340","article-title":"A novel COL4A3 mutation causes autosomal-recessive Alport syndrome in a large Turkish family.","volume":"17","author":"Uzak","year":"2013","journal-title":"Genet Test Mol Biomarkers"},{"key":"R13-20250504","first-page":"5243137","article-title":"A novel homozygous mutation in the COL4A4 gene (Gly1436del) causing Alport syndrome exposed by pregnancy: a case report and review of the literature.","volume":"2022","author":"Jehn","year":"2022","journal-title":"Case Rep Nephrol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"302","DOI":"10.5414\/CN110540","article-title":"Autosomal recessive Alport syndrome caused by a novel COL4A4 compound heterozygous mutation: a case report.","volume":"96","author":"Liao","year":"2021","journal-title":"Clin Nephrol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.2215\/CJN.09100817","article-title":"COL4A3 gene variants and diabetic kidney disease in MODY.","volume":"13","author":"Wang","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1681\/ASN.2020071065","article-title":"Prevalence estimates of predicted pathogenic COL4A3-COL4A5 variants in a population sequencing database and their implications for Alport syndrome.","volume":"32","author":"Gibson","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"e00741","DOI":"10.1002\/mgg3.741","article-title":"Genotype-phenotype correlation and prognostic impact in Chinese patients with Alport Syndrome.","volume":"7","author":"Shang","year":"2019","journal-title":"Mol Genet Genomic Med"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s40620-023-01570-7","article-title":"Clinical, histological and molecular characteristics of Alport syndrome in Chinese children.","volume":"36","author":"Zhou","year":"2023","journal-title":"J Nephrol"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00404-015-3893-9","article-title":"Pregnancy outcomes in patients with Alport syndrome.","volume":"293","author":"Yefet","year":"2016","journal-title":"Arch Gynecol Obstet"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"374020","DOI":"10.1155\/2013\/374020","article-title":"Alport\u2019s syndrome in pregnancy.","volume":"2013","author":"Mehta","year":"2013","journal-title":"Case Rep Med"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s00404-018-4720-x","article-title":"Alport syndrome and pregnancy: a case series and literature review.","volume":"297","author":"Brunini","year":"2018","journal-title":"Arch Gynecol Obstet"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"936","DOI":"10.34067\/KID.0000372019","article-title":"Heterozygous urinary abnormality-causing variants of COL4A3 and COL4A4 affect severity of autosomal recessive Alport syndrome.","volume":"1","author":"Horinouchi","year":"2020","journal-title":"Kidney360"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.phrs.2016.03.017","article-title":"RAAS inhibition and the course of Alport syndrome.","volume":"107","author":"Savva","year":"2016","journal-title":"Pharmacol Res"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000036057","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T08:01:59Z","timestamp":1746345719000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000036057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,17]]},"references-count":23,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000036057","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2023,11,17]]}}}